Alpha-linolenic acid(ALA)is capable of synthesizing eicosapentaenoic acid(EPA)and docosahexaenoic acid(DHA)in vivo,but the conversion rate is hard to meet the body's need for rapid DHA supplementation.Studies have...Alpha-linolenic acid(ALA)is capable of synthesizing eicosapentaenoic acid(EPA)and docosahexaenoic acid(DHA)in vivo,but the conversion rate is hard to meet the body's need for rapid DHA supplementation.Studies have shown that fucoxanthin can increase DHA content in the liver of mice,but the mechanism is not clear.Moreover,the effect of fucoxanthin and its metabolite fucoxanthinol on the chain lengthening reaction of n-6 polyunsaturated fatty acids(PUFAs)is little studied.In this study,the effects of fucoxanthin and fucoxanthinol on the chain elongation of n-3 and n-6 series PUFAs were investigated in mice.Results showed that fucoxanthin and fucoxanthinol significantly increased the conversion of n-3 series ALA to DHA and n-6 series linolenic acid(LA)to arachidonic acid(AA)in the serum,liver,small intestine,and heart of mice.In addition,fucoxanthin accelerated the rate of DHA supplementation by ALA in the brain.Further mechanistic studies revealed that the role of fucoxanthin in promoting PUFAs conversion was not regulated at transcriptional level,but by increasing the activity of fatty acid desaturase 2(FADS2),a key enzyme of chain elongation reaction of n-3 and n-6 PUFAs.This study fundamentally provided theoretical bases for a new strategy of dietary supplementation of n-3 and n-6 PUFAs.展开更多
Background:Fucoxanthin,a carotenoid derived from brown seaweeds,has gained attention as a promising ingredient in skincare due to its antioxidant,anti-inflammatory,anti-aging,and photoprotective properties.Objective:T...Background:Fucoxanthin,a carotenoid derived from brown seaweeds,has gained attention as a promising ingredient in skincare due to its antioxidant,anti-inflammatory,anti-aging,and photoprotective properties.Objective:This review aims to provide a comprehensive analysis of the cosmeceutical potential of fucoxanthin,summarizing findings from in vitro and in vivo studies,as well as clinical trials.Methods:A systematic review(2000–2023)using PubMed,Scopus,Web of Science,and Google Scholar identified studies on fucoxanthin's anti-aging and skin-related properties.Following a three-phase screening process(titles,abstracts,and full-text evaluation),14 relevant studies were selected—9 in vitro and 5 in vivo/clinical—exploring fucoxanthin's effects in cosmetics and skincare.Key outcomes,including effects on oxidative stress,collagen synthesis,melanin production,and skin health,were analyzed.Results:The results from nine in vitro studies showed that fucoxanthin effectively reduces oxidative stress,enhances procollagen synthesis,inhibits matrix metalloproteinases,and suppresses melanin synthesis in various skin cell lines,indicating its potential in preventing skin aging,reducing pigmentation,and improving skin structure and elasticity.In vivo studies,including experiments on ultraviolet B(UVB)-irradiated guinea pigs and hairless mice,demonstrated that fucoxanthin could protect against ultraviolet(UV)-induced skin damage,prevent wrinkle formation,and reduce inflammation.Furthermore,a clinical study involving Korean women confirmed significant improvements in skin moisture,elasticity,and reduction of wrinkles after eight weeks of applying a fucoxanthin-based cream.This review underscores the increasing evidence of fucoxanthin's efficacy in the skin and highlights its cosmetic potential as a main ingredient of innovative,natural,and sustainable cosmeceutical formulations targeting the skin's overall health and preventing aging.Conclusions:Fucoxanthin demonstrates considerable potential as a natural and sustainable component in cosmeceutical formulations for skin beauty and anti-aging.Stability issues,together with bioavailability problems and sourcing,remain an ongoing obstacle to further development.Further research on clinical trials alongside new formulation strategies will help address restrictions that block fucoxanthin from successful cosmetics applications.展开更多
Fucoxanthin,a kind of exclusively algae-derived carotenoids,could reduce lipid content and regulate gut microbiota composition in obese mice,showing potential in preventing hyperlipidemia.This study aimed to illustrat...Fucoxanthin,a kind of exclusively algae-derived carotenoids,could reduce lipid content and regulate gut microbiota composition in obese mice,showing potential in preventing hyperlipidemia.This study aimed to illustrate fucoxanthin efficacy in modulating lipid metabolism in serum and liver of high-fat-induced hyperlipidemia mice,as well as investigate the underlying association with gut microbiota changes.Results showed that fucoxanthin significantly reduced body weight gain and body white fat of the mice.In the serum,total triglycerides(TG),total cholesterol(TC)contents were significantly decreased and high-densitylipoprotein cholesterol levels was significantly upregulated.Moreover,fucoxanthin remarkedly prevented lipid accumulation in the liver.Especially,metabolomics results showed that lipids and lipid-like molecules were significantly downregulated compared with the control,indicating the advance of hepatic lipid metabolism.Bile acids profile in the liver was also greatly changed by fucoxanthin.Meanwhile,fucoxanthin remodeled gut microbiota composition and promoted the relative abundance of Desulfovibrio,Blautia and Clostridia genera.Finally,correlation analysis revealed that these gut microbiota changes were closely related with hepatic metabolites/metabolism and serum lipids.Altogether,this study showed great potential of fucoxanthin in improving serum lipids profile,hepatic lipids and bile acids metabolism of hyperlipidemia mice,which was associated with gut microbiota alteration.展开更多
Postprandial hyperglycemia is an early indication of type 2 diabetes and the target of many anti-diabetic and anti-obesity studies.α-Glucosidase and α-amylase are the crucial factors in regulating starch digestion a...Postprandial hyperglycemia is an early indication of type 2 diabetes and the target of many anti-diabetic and anti-obesity studies.α-Glucosidase and α-amylase are the crucial factors in regulating starch digestion and glucose absorption,making them key targets for many studies to treat postprandial hyperglycemia.We studied the inhibitory activities of microalgal fucoxanthin against rat-intestinalα-glucosidase and pancreaticα-amylase along with the antidiabetic eff ect to induce diff erentiation in 3T3-L1 pre-adipocytes using Oil Red-O staining.Fucoxanthin displayed strong hindrance activities towardα-amylase in a concentration-dependent manner,with an IC50 value of 0.68mmol/L,whereas weak inhibitory activity against α-glucosidase,with an IC 50 value of 4.75 mmol/L.Fucoxanthin also considerably elevated glucose oxidase activity in 3T3-L1 cells by 31.3%at 5μmol/L.During adipocyte differentiation,fucoxanthin showed lipid accumulation in 3T3-L1 cells with no cytotoxicity up to 20μmol/L.However,fucoxanthin had no inhibitory activity on glucose-6-phosphate dehydrogenase.These results suggest that fucoxanthin might be useful for the prevention of obesity or diabetes by inhibiting carbohydrate-hydrolyzing enzymes and lipid accumulation and be utilized as an ingredient for a functional food or dietary supplement.展开更多
Fucoxanthin is a xanthophyll-type carotenoid that provides many benefits to human health. However, the mechanism by which fucoxanthin interacts with microbes and inhibits pathogenic bacteria is unknown. In this study,...Fucoxanthin is a xanthophyll-type carotenoid that provides many benefits to human health. However, the mechanism by which fucoxanthin interacts with microbes and inhibits pathogenic bacteria is unknown. In this study, we investigated the effects of fucoxanthin isolated from the edible seaweed Undaria pinnatifida on pathogenic bacteria Escherichia coli and lactobacilli both in vitro and in vivo. Fucoxanthin strongly inhibited the growth of Gram-positive pathogenic bacteria but was less effective against Gram-negative bacteria. Fucoxanthin extracted from the crude mixture had a recovery rate of 93.38% and a purity of 82.70%, which were higher than those of fucoxanthin extracted using a previous method. Fucoxanthin also promoted the growth of intestinal mi- crobes in mice. Fucoxanthinol, a metabolite of fucoxanthin, was generated in the culture media. Fucoxanthin can be deacetylated into fucoxanthinol not only by conventional digestive enzymes in the digestive tract, but also by E. coli and lactobacilli in the intestine. These results indicate that fucoxanthin interacts with and influences E. coli and lactobacilli in the intestine. Therefore, fucoxanthin isolated from Undaria pinnatifida possibly can be applied in human health maintenance.展开更多
Phaeodactylum tricornutum is a potential livestock for the combined production of eicosapentaenoic acid(EPA) and fucoxanthin. In this study, six marine diatom strains identified as P. tricornutum were cultured and the...Phaeodactylum tricornutum is a potential livestock for the combined production of eicosapentaenoic acid(EPA) and fucoxanthin. In this study, six marine diatom strains identified as P. tricornutum were cultured and their total lipid, fatty acid composition and major photosynthetic pigments determined. It was found that the cell dry weight concentration and mean growth rate ranged between 0.24–0.36 g/L and 0.31–0.33/d, respectively. Among the strains, SCSIO771 presented the highest total lipid content, followed by SCSIO828, and the prominent fatty acids in all strains were C16:0, C16:1, C18:1, and C20:5(EPA). Polyunsaturated fatty acids, including C16:2, C18:2, and EPA, comprised a significant proportion of the total fatty acids. EPA was markedly high in all strains, with the highest in SCSIO828 at 25.65% of total fatty acids. Fucoxanthin was the most abundant pigment in all strains, with the highest in SCSIO828 as well, at 5.50 mg/g. The collective results suggested that strain SCSIO828 could be considered a good candidate for the concurrent production of EPA and fucoxanthin.展开更多
Dietary intake of 0.1% fucoxanthin significantly reduced lipid hydroperoxide levels of liver and abdominal white adipose tissue (WAT) of obese/diabetes KK-Ay mice. The fucoxanthin supplementation also significantly re...Dietary intake of 0.1% fucoxanthin significantly reduced lipid hydroperoxide levels of liver and abdominal white adipose tissue (WAT) of obese/diabetes KK-Ay mice. The fucoxanthin supplementation also significantly reduced blood glucose level and hepatic lipid contents of the mice. Oxidative stress is known to be induced in hyperglycemia and high fat conditions. Therefore, in vivo antioxidant activity of fucoxanthin found in the present study could be attributed to its anti-diabetic effect and its decreasing effect on hepatic lipids. On the other hand, little effect of fucoxanthin on lipid hydroperoxide levels was found in normal ICR mice. Although the content of fucoxanthin metabolites in the abdominal WAT of KK-Ay mice was about 50 times higher that in the liver, there was little difference in its In Vivo antioxidant activity between in the liver and in the abdominal WAT. These results suggest that well-known ability of fucoxanthin to scavenge active oxygen species and/or free radicals would not be a main reason to explain its In Vivo antioxidant activity.展开更多
Objective:To explore the impact of fucoxanthin on oxidized low-density lipoprotein(OxLDL)-induced stress and inflammation in human endothelial cells and its underlying mechanisms.Methods:HUVECs were treated with OxLDL...Objective:To explore the impact of fucoxanthin on oxidized low-density lipoprotein(OxLDL)-induced stress and inflammation in human endothelial cells and its underlying mechanisms.Methods:HUVECs were treated with OxLDL and/or fucoxanthin for a range of time points and concentrations.We evaluated the effects of fucoxanthin on OxLDL-induced HUVECs using the MTT assay,reactive oxygen species accumulation assay,ELISA,RT-PCR,immunofluorescence,and Western blotting.Results:Fucoxanthin enhanced the cell viability in a dose dependent manner after OxLDL exposure.Furthermore,fucoxanthin pretreatment significantly decreased OxLDL-induced reactive oxygen species production and prevented the activation of the nuclear factor kappa-B pathway,which led to substantial suppression of pro-inflammatory gene expressions.OxLDL-induced upregulation of interleukin-6,intercellular adhesion molecule-1,vascular cell adhesion molecule-1,interleukin-1β,monocyte chemotactic protein-1,cyclooxygenase-1,and tumor necrosis factor-αwas significantly reduced by fucoxanthin.Conclusions:Fucoxanthin can inhibit OxLDL-induced vascular inflammation and oxidative stress in HUVECs by targeting Nrf2 signaling pathways.展开更多
In a previous study from our laboratory, fucoxanthin purified from brown algae, Sargassum wightii Greville has found to exhibit antioxidant activity and inhibition of angiotensin-I-converting enzyme(ACE)in vitro. The ...In a previous study from our laboratory, fucoxanthin purified from brown algae, Sargassum wightii Greville has found to exhibit antioxidant activity and inhibition of angiotensin-I-converting enzyme(ACE)in vitro. The present study aims in understanding the protective effect of fucoxanthin purified from S. wightii against diabetes with hypertension in in vivo. Diabetes and hypertension were induced in rat by streptozotocin and sodium chloride treatment, respectively. In diabetes with hypertension rat, the blood pressure was increased along with hyperglycemia. Administration of fucoxanthin significantly reduced the blood pressure and ACE activity in diabetes with hypertension rat. Furthermore, administration of fucoxanthin significantly reduced the hyperglycemic state. The activity of various enzymes in the liver(hexokinase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-phosphatase)and serum(creatine kinase)were normalized to that of control level. The level of glycogen, glycoprotein component and lipid profile were equivalent to control level by fucoxanthin administration in diabetes with hypertension rats. Fucoxanthin ameliorated the oxidative stress by preserving the endogenous antioxidant levels in diabetes with hypertension rats. Also, the pancreatic histological integrity was similar to that of control level in diabetes with hypertension rats by fucoxanthin treatment. Altogether, fucoxanthin showed dual antidiabetic and antihypertensive activity in vivo.展开更多
This study aims to （1） obtain a pure extract of Sargassumfilipendula fucoxanthin, （2） determine the effect of concentration of fucoxanthin against HeLa cells, and （3） determine the effect of concentration of fuc...This study aims to （1） obtain a pure extract of Sargassumfilipendula fucoxanthin, （2） determine the effect of concentration of fucoxanthin against HeLa cells, and （3） determine the effect of concentration of fucoxanthin against cancer cell lymphocytes. The benefit of this research is to find out that fucoxanthin can be used as an anti-cancer treatment. The study was conducted in September 2013 at the Laboratory of Fishery Product Technology FPIK UB and UB Medical Biomedical Laboratories, Malang. Sampling brown seaweed （Sargassum filipendula） of the District Rural Padike Talango Sumenep Madura. Extracted isolated by column chromatography using silica gel stationary phase and mobile phase hexane：ethyl acetate （6：4, v/v） ± 100 mL, then identified by TLC using the stationary phase, a silica gel F-254 HPLC with ODS stationary phase （C-18） 5 mL with a mobile phase of methanol, acetone and ammonium acetate （IM） （80：10：10, v/v） and a flow rate of 1.0 mL/min pigment solution of 20 mL compared with the standard of Japan. Research results indicate that, spectra maximum wavelength of 450 nm and 446 nm with a minimum of acetone solvent. HPLC has the same retention time = 10.12 standard, namely Sargassum filipendula = 10.11. By giving some of the best concentrations at 100 ppm is lethal HeLa cells ebesar 5236% which means that fucoxanthin effect against HeLa cells have the potential fucoxanthin that can induce cell apoptosis that occurs in HeLa cells, it is possible because of the anti-carcinogenic fucoxanthin mempuyai structure unique. While the cell lymphocytes in the dosage of 100 ppm were dead at 8.788%, the effect of the toxicity of a substance can be observed from how many dead lymphocytes when compared with the state charity by observing level of lymphocyte proliferation.展开更多
Macroalgae serve as a potential feedstock for fucoxanthin extraction.Fucoxanthin,a bioactive pigment found in the chloroplasts of marine algae,exhibits significant pharmacological properties.As a member of the caroten...Macroalgae serve as a potential feedstock for fucoxanthin extraction.Fucoxanthin,a bioactive pigment found in the chloroplasts of marine algae,exhibits significant pharmacological properties.As a member of the carotenoid family,fucoxanthin plays a crucial role in both the food and pharmaceutical industries.This research explores the effects of ultrasonics on the extraction of fucoxanthin from the marine macroalga Padina australis.In addition,various extraction techniques and the influence of solvents on the efficient separation of fucoxanthin from algae have been studied and compared.Using methanol,chloroform,and a combination of methanol and chloroform(1:1,v/v),conventional fucoxanthin extraction from Padina australis yielded 8.12 mg of fucoxanthin per gram of biomass.However,the ultrasonic-assisted extraction resulted in a significantly higher yield of 16.9 mg of fucoxanthin per gram of biomass,demonstrating that the use of ultrasonics enhances the extraction rate compared to conventional methods.Therefore,the efficient separation of fucoxanthin from Padina australis is highly dependent on ultrasonic-assisted extraction.The process conditions for the extraction were optimized to maximize the yield of fucoxanthin from seaweeds.The following parameters were selected for optimization studies:moisture content,particle size,mixing speed,extraction temperature,extraction duration,and solid-to-solvent ratio.The extracted fucoxanthin exhibited various biological activities,including antimicrobial and antioxidant properties,and its structure was elucidated through FTIR and NMR spectroscopy.Additionally,thin-layer chromatography of the crude algae extracts confirmed the presence of fucoxanthin in the marine algae.Given these findings,the optimized extraction process holds the potential for scaling up to large-scale fucoxanthin production.Fucoxanthin,as a potent pharmacological agent,offers promising applications in the treatment of various ailments.展开更多
Fucoxanthin was extracted from the intact rhizoid of Laminariajaponica Aresch with dimethyl sulfoxide （DMSO）, and then recovered from the DMSO extract by partitioning into ethyl acetate and subsequent evaporation. S...Fucoxanthin was extracted from the intact rhizoid of Laminariajaponica Aresch with dimethyl sulfoxide （DMSO）, and then recovered from the DMSO extract by partitioning into ethyl acetate and subsequent evaporation. Some isolation conditions such as solvent volume and extraction time were screened. The quantity and quality of the extracted fucoxanthin were determined by spectral analysis （absorption spectra and fluorescence emission spectra）. The results indicated that： （1） the average total content of fucoxanthin was 122.1μg in 1 g of fresh L. japonica rhizoid; （2） in comparison with the widely used organic solvent, acetone, DMSO was much more effective for the extraction of fucoxanthin; （3） both DMSO volume and extraction time influenced extraction efficiency such as the recovery rate and purity of fucoxanthin （1 g of fresh L. japonica rhizoid treated with 4 mL DMSO for 60 min, yielded 〉 88% of the total fucoxanthin with purity 0.63）; （4） when （NH4）2SO4 concentration was in the range of 0.5-1.0 mol/L, the pigments rapidly and entirely moved from DMSO into the ethyl acetate phase; （5） the ethyl acetate and DMSO were recycled using a rotary evaporator.展开更多
The objective of this study was to isolate fucoxanthin from Sargassum thunbergii and develop microcapsules with palm stearin as the solid lipid core for stability and efficient oral delivery of fucoxanthin. The microc...The objective of this study was to isolate fucoxanthin from Sargassum thunbergii and develop microcapsules with palm stearin as the solid lipid core for stability and efficient oral delivery of fucoxanthin. The microcapsules had smooth surfaces with the volume weighted mean diameter （d4.3） of 19.19 μm. Encapsulation efficiency and loading capacity of microcapsules with fucoxanthin were 98.3% and 0.04%, respectively. Moreover, the fucoxanthin in microcapsules presented higher stability than free fucoxanthin against light, humidity and temperature. Especially, the retention rates of fucoxanthin encapsulated in microcapsules reached 97.20% at 4℃, 92.60% at 25℃, 92.32% with the relative humidity of 33% and 92.60% in the dark. The cumulative amount of fucoxanthin released from microcapsules was 22.92% in simulated gastric fluid （SGF） and 56.55% in simulated intestinal fluid （SIF）.展开更多
Isochrysis galbana is considered an ideal bait for functional foods and nutraceuticals of humans because of its high fucoxanthin(Fx)content.However,multi-omics analysis of the regulatory networks for Fx biosynthesis i...Isochrysis galbana is considered an ideal bait for functional foods and nutraceuticals of humans because of its high fucoxanthin(Fx)content.However,multi-omics analysis of the regulatory networks for Fx biosynthesis in I.galbana has not been reported.In this study,we report a high-quality genome assembly of I.galbana LG007,which has a genome size of 92.73 Mb,with a contig N50 of 6.99 Mb and 14,900 protein-coding genes.Phylogenetic analysis confirmed the monophyly of Haptophyta,with I.galbana sister to Emiliania huxleyi and Chrysochromulina tobinii.Evolutionary analysis revealed an estimated divergence time between I.galbana and E.huxleyi of~133 million years ago.Gene family analysis indicated that lipid metabolism-related genes exhibited significant expansion,including IgPLMT,IgOAR1,and IgDEGS1.Metabolome analysis showed that the content of carotenoids in I.galbana cultured under green light for 7 days was higher than that under white light,andβ-carotene was the main carotenoid,accounting for 79.09%of the total carotenoids.Comprehensive multi-omics analysis revealed that the content ofβ-carotene,antheraxanthin,zeaxanthin,and Fx was increased by green light induction,which was significantly correlated with the expression of IgMYB98,IgZDS,IgPDS,IgLHCX2,IgZEP,IgLCYb,and IgNSY.These findings contribute to the understanding of Fx biosynthesis and its regulation,providing a valuable reference for food and pharmaceutical applications.展开更多
The pigments are vital parts of photosynthetic machinery in algae and exhibit a myriad of applications as nutraceuticals,cosmetics,colorants,which find huge applications in many industires,including the paint industry...The pigments are vital parts of photosynthetic machinery in algae and exhibit a myriad of applications as nutraceuticals,cosmetics,colorants,which find huge applications in many industires,including the paint industry and paper industry.The antimicrobial,antioxidative,anti-inflammatory,and anti-cancer potential of microalgal pigments contribute towards their varied industrial applications.In this study,pigments(Fucoxanthin,C-phycocyanin,and C-phycoerythrin),extracted from microalgae were investigated to check the antimicrobial efficacy using agar well diffusion and disc diffusion methods against pathogenic bacteria:Staphylococcus aureus and Escherichia coli.The fucoxanthin pigment isolated from diatom Thalassiosira sp.exhibited the highest antibacterial activity against Staphylococcus aureus(17±1.53 mm)and in contrast fucoxanthin pigment isolated from Chaetoceroes sp.exhibited the highest bactericidal activity against Escherichia coli(18±1).The pigment extract of Spirulina plantesis showed the highest antibacterial activity against E.coli(41±0.3)and S.elongatus also exhibited high antibacterial activity against E.coli(32±0.5)while Anabaena variabilis showed the highest antibacterial activity against Staphylococcus aureus(34±0.5).The potential of microalgal pigments is highly valuable and further extensive studies can elaborate the underlying mechanisms.展开更多
基金supported by Qingdao Marine Science and Technology Center(2022QNLM030003-1)Taishan Scholars Program(tstp20240812)+3 种基金Youth Innovation Team Program of Universities in Shandong Province(2023KJ040)Open Foundation of State Key Laboratory of Marine Food Processing&Safety Control(SKL202412)China Postdoctoral Science Foundation(2024M763107)Postdoctoral Fellowship Program of CPSF(GZC20241617)。
文摘Alpha-linolenic acid(ALA)is capable of synthesizing eicosapentaenoic acid(EPA)and docosahexaenoic acid(DHA)in vivo,but the conversion rate is hard to meet the body's need for rapid DHA supplementation.Studies have shown that fucoxanthin can increase DHA content in the liver of mice,but the mechanism is not clear.Moreover,the effect of fucoxanthin and its metabolite fucoxanthinol on the chain lengthening reaction of n-6 polyunsaturated fatty acids(PUFAs)is little studied.In this study,the effects of fucoxanthin and fucoxanthinol on the chain elongation of n-3 and n-6 series PUFAs were investigated in mice.Results showed that fucoxanthin and fucoxanthinol significantly increased the conversion of n-3 series ALA to DHA and n-6 series linolenic acid(LA)to arachidonic acid(AA)in the serum,liver,small intestine,and heart of mice.In addition,fucoxanthin accelerated the rate of DHA supplementation by ALA in the brain.Further mechanistic studies revealed that the role of fucoxanthin in promoting PUFAs conversion was not regulated at transcriptional level,but by increasing the activity of fatty acid desaturase 2(FADS2),a key enzyme of chain elongation reaction of n-3 and n-6 PUFAs.This study fundamentally provided theoretical bases for a new strategy of dietary supplementation of n-3 and n-6 PUFAs.
基金the Ministry of Higher Education of Malaysia(MOHE)and She Empire Sdn Bhd for their financial support under the Industry Matching Programme(IMaP)(Ref:IMaP/1/2024/SKK15/UTHM//1)for the project titled“FusionDerm Validation:Pioneering the Next-Generation Multipurpose Cream with Fucoxanthin for Enhanced Urban Skin Defense and Anti-Pollution Efficacy.”。
文摘Background:Fucoxanthin,a carotenoid derived from brown seaweeds,has gained attention as a promising ingredient in skincare due to its antioxidant,anti-inflammatory,anti-aging,and photoprotective properties.Objective:This review aims to provide a comprehensive analysis of the cosmeceutical potential of fucoxanthin,summarizing findings from in vitro and in vivo studies,as well as clinical trials.Methods:A systematic review(2000–2023)using PubMed,Scopus,Web of Science,and Google Scholar identified studies on fucoxanthin's anti-aging and skin-related properties.Following a three-phase screening process(titles,abstracts,and full-text evaluation),14 relevant studies were selected—9 in vitro and 5 in vivo/clinical—exploring fucoxanthin's effects in cosmetics and skincare.Key outcomes,including effects on oxidative stress,collagen synthesis,melanin production,and skin health,were analyzed.Results:The results from nine in vitro studies showed that fucoxanthin effectively reduces oxidative stress,enhances procollagen synthesis,inhibits matrix metalloproteinases,and suppresses melanin synthesis in various skin cell lines,indicating its potential in preventing skin aging,reducing pigmentation,and improving skin structure and elasticity.In vivo studies,including experiments on ultraviolet B(UVB)-irradiated guinea pigs and hairless mice,demonstrated that fucoxanthin could protect against ultraviolet(UV)-induced skin damage,prevent wrinkle formation,and reduce inflammation.Furthermore,a clinical study involving Korean women confirmed significant improvements in skin moisture,elasticity,and reduction of wrinkles after eight weeks of applying a fucoxanthin-based cream.This review underscores the increasing evidence of fucoxanthin's efficacy in the skin and highlights its cosmetic potential as a main ingredient of innovative,natural,and sustainable cosmeceutical formulations targeting the skin's overall health and preventing aging.Conclusions:Fucoxanthin demonstrates considerable potential as a natural and sustainable component in cosmeceutical formulations for skin beauty and anti-aging.Stability issues,together with bioavailability problems and sourcing,remain an ongoing obstacle to further development.Further research on clinical trials alongside new formulation strategies will help address restrictions that block fucoxanthin from successful cosmetics applications.
基金funded by the National Natural Science Foundation of China(31901624)the Key-Area Research and Development Program of Guangdong Province(2018B020206001)+2 种基金Guangdong Province Zhujiang Talent Program(2019ZT08H476)Shenzhen Science and Technology Program(KQTD20180412181334790)the Innovation Team Project of Universities in Guangdong Province(2020KCXTD023)。
文摘Fucoxanthin,a kind of exclusively algae-derived carotenoids,could reduce lipid content and regulate gut microbiota composition in obese mice,showing potential in preventing hyperlipidemia.This study aimed to illustrate fucoxanthin efficacy in modulating lipid metabolism in serum and liver of high-fat-induced hyperlipidemia mice,as well as investigate the underlying association with gut microbiota changes.Results showed that fucoxanthin significantly reduced body weight gain and body white fat of the mice.In the serum,total triglycerides(TG),total cholesterol(TC)contents were significantly decreased and high-densitylipoprotein cholesterol levels was significantly upregulated.Moreover,fucoxanthin remarkedly prevented lipid accumulation in the liver.Especially,metabolomics results showed that lipids and lipid-like molecules were significantly downregulated compared with the control,indicating the advance of hepatic lipid metabolism.Bile acids profile in the liver was also greatly changed by fucoxanthin.Meanwhile,fucoxanthin remodeled gut microbiota composition and promoted the relative abundance of Desulfovibrio,Blautia and Clostridia genera.Finally,correlation analysis revealed that these gut microbiota changes were closely related with hepatic metabolites/metabolism and serum lipids.Altogether,this study showed great potential of fucoxanthin in improving serum lipids profile,hepatic lipids and bile acids metabolism of hyperlipidemia mice,which was associated with gut microbiota alteration.
基金a part of the project titled ’Future Marine Technology Development’ funded by the Ministry of Oceans and Fisheries, Republic of Korea
文摘Postprandial hyperglycemia is an early indication of type 2 diabetes and the target of many anti-diabetic and anti-obesity studies.α-Glucosidase and α-amylase are the crucial factors in regulating starch digestion and glucose absorption,making them key targets for many studies to treat postprandial hyperglycemia.We studied the inhibitory activities of microalgal fucoxanthin against rat-intestinalα-glucosidase and pancreaticα-amylase along with the antidiabetic eff ect to induce diff erentiation in 3T3-L1 pre-adipocytes using Oil Red-O staining.Fucoxanthin displayed strong hindrance activities towardα-amylase in a concentration-dependent manner,with an IC50 value of 0.68mmol/L,whereas weak inhibitory activity against α-glucosidase,with an IC 50 value of 4.75 mmol/L.Fucoxanthin also considerably elevated glucose oxidase activity in 3T3-L1 cells by 31.3%at 5μmol/L.During adipocyte differentiation,fucoxanthin showed lipid accumulation in 3T3-L1 cells with no cytotoxicity up to 20μmol/L.However,fucoxanthin had no inhibitory activity on glucose-6-phosphate dehydrogenase.These results suggest that fucoxanthin might be useful for the prevention of obesity or diabetes by inhibiting carbohydrate-hydrolyzing enzymes and lipid accumulation and be utilized as an ingredient for a functional food or dietary supplement.
基金supported by the Independent Innovation Major Project of Huangdao District, Qingdao City (No. 2014-3-11)the National Natural Science Foundation of China (No. 31371731)
文摘Fucoxanthin is a xanthophyll-type carotenoid that provides many benefits to human health. However, the mechanism by which fucoxanthin interacts with microbes and inhibits pathogenic bacteria is unknown. In this study, we investigated the effects of fucoxanthin isolated from the edible seaweed Undaria pinnatifida on pathogenic bacteria Escherichia coli and lactobacilli both in vitro and in vivo. Fucoxanthin strongly inhibited the growth of Gram-positive pathogenic bacteria but was less effective against Gram-negative bacteria. Fucoxanthin extracted from the crude mixture had a recovery rate of 93.38% and a purity of 82.70%, which were higher than those of fucoxanthin extracted using a previous method. Fucoxanthin also promoted the growth of intestinal mi- crobes in mice. Fucoxanthinol, a metabolite of fucoxanthin, was generated in the culture media. Fucoxanthin can be deacetylated into fucoxanthinol not only by conventional digestive enzymes in the digestive tract, but also by E. coli and lactobacilli in the intestine. These results indicate that fucoxanthin interacts with and influences E. coli and lactobacilli in the intestine. Therefore, fucoxanthin isolated from Undaria pinnatifida possibly can be applied in human health maintenance.
基金Supported by the Knowledge Innovation Program of Chinese Academy of Sciences(No.SQ201213)the National Natural Science Foundation of China(No.31402320)+1 种基金the Guangdong Province and Chinese Academy of Science Cooperation Foundation(No.2012B091100268)the Technology Project of Ocean and Fisheries of Guangdong Province(No.A201101I04)
文摘Phaeodactylum tricornutum is a potential livestock for the combined production of eicosapentaenoic acid(EPA) and fucoxanthin. In this study, six marine diatom strains identified as P. tricornutum were cultured and their total lipid, fatty acid composition and major photosynthetic pigments determined. It was found that the cell dry weight concentration and mean growth rate ranged between 0.24–0.36 g/L and 0.31–0.33/d, respectively. Among the strains, SCSIO771 presented the highest total lipid content, followed by SCSIO828, and the prominent fatty acids in all strains were C16:0, C16:1, C18:1, and C20:5(EPA). Polyunsaturated fatty acids, including C16:2, C18:2, and EPA, comprised a significant proportion of the total fatty acids. EPA was markedly high in all strains, with the highest in SCSIO828 at 25.65% of total fatty acids. Fucoxanthin was the most abundant pigment in all strains, with the highest in SCSIO828 as well, at 5.50 mg/g. The collective results suggested that strain SCSIO828 could be considered a good candidate for the concurrent production of EPA and fucoxanthin.
文摘Dietary intake of 0.1% fucoxanthin significantly reduced lipid hydroperoxide levels of liver and abdominal white adipose tissue (WAT) of obese/diabetes KK-Ay mice. The fucoxanthin supplementation also significantly reduced blood glucose level and hepatic lipid contents of the mice. Oxidative stress is known to be induced in hyperglycemia and high fat conditions. Therefore, in vivo antioxidant activity of fucoxanthin found in the present study could be attributed to its anti-diabetic effect and its decreasing effect on hepatic lipids. On the other hand, little effect of fucoxanthin on lipid hydroperoxide levels was found in normal ICR mice. Although the content of fucoxanthin metabolites in the abdominal WAT of KK-Ay mice was about 50 times higher that in the liver, there was little difference in its In Vivo antioxidant activity between in the liver and in the abdominal WAT. These results suggest that well-known ability of fucoxanthin to scavenge active oxygen species and/or free radicals would not be a main reason to explain its In Vivo antioxidant activity.
基金Deanship of Scientific Research at King Faisal University Saudi Arabia,grant number 187006,funded this research.
文摘Objective:To explore the impact of fucoxanthin on oxidized low-density lipoprotein(OxLDL)-induced stress and inflammation in human endothelial cells and its underlying mechanisms.Methods:HUVECs were treated with OxLDL and/or fucoxanthin for a range of time points and concentrations.We evaluated the effects of fucoxanthin on OxLDL-induced HUVECs using the MTT assay,reactive oxygen species accumulation assay,ELISA,RT-PCR,immunofluorescence,and Western blotting.Results:Fucoxanthin enhanced the cell viability in a dose dependent manner after OxLDL exposure.Furthermore,fucoxanthin pretreatment significantly decreased OxLDL-induced reactive oxygen species production and prevented the activation of the nuclear factor kappa-B pathway,which led to substantial suppression of pro-inflammatory gene expressions.OxLDL-induced upregulation of interleukin-6,intercellular adhesion molecule-1,vascular cell adhesion molecule-1,interleukin-1β,monocyte chemotactic protein-1,cyclooxygenase-1,and tumor necrosis factor-αwas significantly reduced by fucoxanthin.Conclusions:Fucoxanthin can inhibit OxLDL-induced vascular inflammation and oxidative stress in HUVECs by targeting Nrf2 signaling pathways.
文摘In a previous study from our laboratory, fucoxanthin purified from brown algae, Sargassum wightii Greville has found to exhibit antioxidant activity and inhibition of angiotensin-I-converting enzyme(ACE)in vitro. The present study aims in understanding the protective effect of fucoxanthin purified from S. wightii against diabetes with hypertension in in vivo. Diabetes and hypertension were induced in rat by streptozotocin and sodium chloride treatment, respectively. In diabetes with hypertension rat, the blood pressure was increased along with hyperglycemia. Administration of fucoxanthin significantly reduced the blood pressure and ACE activity in diabetes with hypertension rat. Furthermore, administration of fucoxanthin significantly reduced the hyperglycemic state. The activity of various enzymes in the liver(hexokinase, glucose-6-phosphate dehydrogenase, glucose-6-phosphatase and fructose-1,6-phosphatase)and serum(creatine kinase)were normalized to that of control level. The level of glycogen, glycoprotein component and lipid profile were equivalent to control level by fucoxanthin administration in diabetes with hypertension rats. Fucoxanthin ameliorated the oxidative stress by preserving the endogenous antioxidant levels in diabetes with hypertension rats. Also, the pancreatic histological integrity was similar to that of control level in diabetes with hypertension rats by fucoxanthin treatment. Altogether, fucoxanthin showed dual antidiabetic and antihypertensive activity in vivo.
文摘This study aims to （1） obtain a pure extract of Sargassumfilipendula fucoxanthin, （2） determine the effect of concentration of fucoxanthin against HeLa cells, and （3） determine the effect of concentration of fucoxanthin against cancer cell lymphocytes. The benefit of this research is to find out that fucoxanthin can be used as an anti-cancer treatment. The study was conducted in September 2013 at the Laboratory of Fishery Product Technology FPIK UB and UB Medical Biomedical Laboratories, Malang. Sampling brown seaweed （Sargassum filipendula） of the District Rural Padike Talango Sumenep Madura. Extracted isolated by column chromatography using silica gel stationary phase and mobile phase hexane：ethyl acetate （6：4, v/v） ± 100 mL, then identified by TLC using the stationary phase, a silica gel F-254 HPLC with ODS stationary phase （C-18） 5 mL with a mobile phase of methanol, acetone and ammonium acetate （IM） （80：10：10, v/v） and a flow rate of 1.0 mL/min pigment solution of 20 mL compared with the standard of Japan. Research results indicate that, spectra maximum wavelength of 450 nm and 446 nm with a minimum of acetone solvent. HPLC has the same retention time = 10.12 standard, namely Sargassum filipendula = 10.11. By giving some of the best concentrations at 100 ppm is lethal HeLa cells ebesar 5236% which means that fucoxanthin effect against HeLa cells have the potential fucoxanthin that can induce cell apoptosis that occurs in HeLa cells, it is possible because of the anti-carcinogenic fucoxanthin mempuyai structure unique. While the cell lymphocytes in the dosage of 100 ppm were dead at 8.788%, the effect of the toxicity of a substance can be observed from how many dead lymphocytes when compared with the state charity by observing level of lymphocyte proliferation.
文摘Macroalgae serve as a potential feedstock for fucoxanthin extraction.Fucoxanthin,a bioactive pigment found in the chloroplasts of marine algae,exhibits significant pharmacological properties.As a member of the carotenoid family,fucoxanthin plays a crucial role in both the food and pharmaceutical industries.This research explores the effects of ultrasonics on the extraction of fucoxanthin from the marine macroalga Padina australis.In addition,various extraction techniques and the influence of solvents on the efficient separation of fucoxanthin from algae have been studied and compared.Using methanol,chloroform,and a combination of methanol and chloroform(1:1,v/v),conventional fucoxanthin extraction from Padina australis yielded 8.12 mg of fucoxanthin per gram of biomass.However,the ultrasonic-assisted extraction resulted in a significantly higher yield of 16.9 mg of fucoxanthin per gram of biomass,demonstrating that the use of ultrasonics enhances the extraction rate compared to conventional methods.Therefore,the efficient separation of fucoxanthin from Padina australis is highly dependent on ultrasonic-assisted extraction.The process conditions for the extraction were optimized to maximize the yield of fucoxanthin from seaweeds.The following parameters were selected for optimization studies:moisture content,particle size,mixing speed,extraction temperature,extraction duration,and solid-to-solvent ratio.The extracted fucoxanthin exhibited various biological activities,including antimicrobial and antioxidant properties,and its structure was elucidated through FTIR and NMR spectroscopy.Additionally,thin-layer chromatography of the crude algae extracts confirmed the presence of fucoxanthin in the marine algae.Given these findings,the optimized extraction process holds the potential for scaling up to large-scale fucoxanthin production.Fucoxanthin,as a potent pharmacological agent,offers promising applications in the treatment of various ailments.
文摘Fucoxanthin was extracted from the intact rhizoid of Laminariajaponica Aresch with dimethyl sulfoxide （DMSO）, and then recovered from the DMSO extract by partitioning into ethyl acetate and subsequent evaporation. Some isolation conditions such as solvent volume and extraction time were screened. The quantity and quality of the extracted fucoxanthin were determined by spectral analysis （absorption spectra and fluorescence emission spectra）. The results indicated that： （1） the average total content of fucoxanthin was 122.1μg in 1 g of fresh L. japonica rhizoid; （2） in comparison with the widely used organic solvent, acetone, DMSO was much more effective for the extraction of fucoxanthin; （3） both DMSO volume and extraction time influenced extraction efficiency such as the recovery rate and purity of fucoxanthin （1 g of fresh L. japonica rhizoid treated with 4 mL DMSO for 60 min, yielded 〉 88% of the total fucoxanthin with purity 0.63）; （4） when （NH4）2SO4 concentration was in the range of 0.5-1.0 mol/L, the pigments rapidly and entirely moved from DMSO into the ethyl acetate phase; （5） the ethyl acetate and DMSO were recycled using a rotary evaporator.
基金This work was supported by Public Science and Technology Research Funds Projects of Ocean （Grant No. 201505022）, the National Natural Science Foundation of China NSFC-Shandong Joint Fund （U1406402-5）, the National Natural Science Foundation of China （Grant No. 81671828）, and the Taishan Scholar Program of China.
文摘The objective of this study was to isolate fucoxanthin from Sargassum thunbergii and develop microcapsules with palm stearin as the solid lipid core for stability and efficient oral delivery of fucoxanthin. The microcapsules had smooth surfaces with the volume weighted mean diameter （d4.3） of 19.19 μm. Encapsulation efficiency and loading capacity of microcapsules with fucoxanthin were 98.3% and 0.04%, respectively. Moreover, the fucoxanthin in microcapsules presented higher stability than free fucoxanthin against light, humidity and temperature. Especially, the retention rates of fucoxanthin encapsulated in microcapsules reached 97.20% at 4℃, 92.60% at 25℃, 92.32% with the relative humidity of 33% and 92.60% in the dark. The cumulative amount of fucoxanthin released from microcapsules was 22.92% in simulated gastric fluid （SGF） and 56.55% in simulated intestinal fluid （SIF）.
基金supported by the National Natural Science Foundation of China(Grant No.42006087)the Sugar Crop Research System,China(Grant No.CARS-170501).
文摘Isochrysis galbana is considered an ideal bait for functional foods and nutraceuticals of humans because of its high fucoxanthin(Fx)content.However,multi-omics analysis of the regulatory networks for Fx biosynthesis in I.galbana has not been reported.In this study,we report a high-quality genome assembly of I.galbana LG007,which has a genome size of 92.73 Mb,with a contig N50 of 6.99 Mb and 14,900 protein-coding genes.Phylogenetic analysis confirmed the monophyly of Haptophyta,with I.galbana sister to Emiliania huxleyi and Chrysochromulina tobinii.Evolutionary analysis revealed an estimated divergence time between I.galbana and E.huxleyi of~133 million years ago.Gene family analysis indicated that lipid metabolism-related genes exhibited significant expansion,including IgPLMT,IgOAR1,and IgDEGS1.Metabolome analysis showed that the content of carotenoids in I.galbana cultured under green light for 7 days was higher than that under white light,andβ-carotene was the main carotenoid,accounting for 79.09%of the total carotenoids.Comprehensive multi-omics analysis revealed that the content ofβ-carotene,antheraxanthin,zeaxanthin,and Fx was increased by green light induction,which was significantly correlated with the expression of IgMYB98,IgZDS,IgPDS,IgLHCX2,IgZEP,IgLCYb,and IgNSY.These findings contribute to the understanding of Fx biosynthesis and its regulation,providing a valuable reference for food and pharmaceutical applications.
基金Financial support for this work was provided by the Department of Biotechnology,New Delhi,India[Grant number BT/PR 15650/AAQ/3/815/2016].
文摘The pigments are vital parts of photosynthetic machinery in algae and exhibit a myriad of applications as nutraceuticals,cosmetics,colorants,which find huge applications in many industires,including the paint industry and paper industry.The antimicrobial,antioxidative,anti-inflammatory,and anti-cancer potential of microalgal pigments contribute towards their varied industrial applications.In this study,pigments(Fucoxanthin,C-phycocyanin,and C-phycoerythrin),extracted from microalgae were investigated to check the antimicrobial efficacy using agar well diffusion and disc diffusion methods against pathogenic bacteria:Staphylococcus aureus and Escherichia coli.The fucoxanthin pigment isolated from diatom Thalassiosira sp.exhibited the highest antibacterial activity against Staphylococcus aureus(17±1.53 mm)and in contrast fucoxanthin pigment isolated from Chaetoceroes sp.exhibited the highest bactericidal activity against Escherichia coli(18±1).The pigment extract of Spirulina plantesis showed the highest antibacterial activity against E.coli(41±0.3)and S.elongatus also exhibited high antibacterial activity against E.coli(32±0.5)while Anabaena variabilis showed the highest antibacterial activity against Staphylococcus aureus(34±0.5).The potential of microalgal pigments is highly valuable and further extensive studies can elaborate the underlying mechanisms.
